HFA Icon

Lakewood Capital Still Shorting Pot Stocks, Korean Biotech

Michelle headshot
Michelle deBoer-Jones
Published on
Updated on
Sign up for our E-mail List and Get FREE Access to Exclusive Investment E-books and More!

The end of 2018 brought a return to reality in the form of a steep bear market for equities. Of course, it created a nearly impossible situation for many funds on the long side, but it was actually good news for some short-sellers. Lakewood Capital was one of those which managed to capitalize on the tumbling stock market through several key short positions.

Q4 hedge fund letters, conference, scoops etc

connection lost 3498366 1280
thomaspedrazzoli / Pixabay

Lakewood Capital sees strong returns on shorts

Reputable short-seller Anthony Bozza said in his annual letter for the fund that their short positions generated a return of 34% for the fourth quarter. However, the strong results from their short portfolio toward the end of the year have them treading lightly now.

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article
Already a member? Log in here
Michelle headshot

Michelle deBoer-Jones is editor-in-chief of Hedge Fund Alpha. She also writes comparative analyses of stocks for TipRanks and runs Providence Writing Services. Previously, she was a television news producer for eight years, producing the morning news programs for NBC affiliates in Evansville, Indiana and Huntsville, Alabama and spending a short time at the CBS affiliate in Huntsville.